Grünenthal’s monthly report for commercial management of Dec. 1960 stated that Contergan sales at the time amounted to almost 50% of the entire volume of sales and that “everything is done to protect our ‘eyeball’”.

Source: Anklageschrift (indictment) from 1967, today archived at the National Archives of North Rhine-Westphalia in Duisburg, Germany (Rheinland Division, Gerichte Rep. 139, No. 1–396), p. 132.